The genetics of Alzheimer's disease

Código QR

The genetics of Alzheimer's disease

Eva Bagyinszky,1 Young Chul Youn,2 Seong Soo A An,1,* SangYun Kim3,*1Department of BioNano Technology Gachon University, Gyeonggi-do, 2Department of Neurology, Chung-Ang University College of Medicine, Seoul, 3Department of Neurology, Seoul National University Budang Hospital, Gyeonggi-do, South Kor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bagyinszky E, Youn YC, An SSA, Kim SY
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	dementia amyloid precursor protein presenilin 1 presenilin 2 APOE mutation diagnosis genetic testing Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/242c3127e1be4c238c2569642f09f086
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
por: Bagyinszky E, et al.
Publicado: (2016)

Genes associated with Alzheimer's disease: an overview and current status
por: Giri M, et al.
Publicado: (2016)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
por: Park KW, et al.
Publicado: (2017)

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau VV, et al.
Publicado: (2018)

An insight into Alzheimer’s disease and its on-setting novel genes
por: Jaanaky Vigneswaran, et al.
Publicado: (2021)

Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months
por: Regal P, et al.
Publicado: (2013)

Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt–Jakob disease
por: Bagyinszky E, et al.
Publicado: (2019)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)

Care pathways for dementia: current perspectives
por: Samsi K, et al.
Publicado: (2014)

Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage
por: Wei Yang, et al.
Publicado: (2021)

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau VV, et al.
Publicado: (2018)

Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
por: Onofri E, et al.
Publicado: (2015)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

“Who to Tell, How and When?”: Development and Preliminary Feasibility of an Empowerment Intervention for People Living with Dementia Who are Fearful of Disclosing Their Diagnosis
por: Bhatt J, et al.
Publicado: (2020)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)

Genetic Analysis of Chinese Patients with Early-Onset Dementia Using Next-Generation Sequencing
por: Han LH, et al.
Publicado: (2020)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

A cross-sectional study of inpatients with late stage of dementia in Southeast China and the associations between biochemical parameters and apolipoprotein E genotypes
por: Jiang B, et al.
Publicado: (2018)

Presenilin 2 overexpression is associated with apoptosis in Neuro2a cells
por: Kumar Ashish, et al.
Publicado: (2016)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Type 2 diabetes as a risk factor for cognitive impairment: current insights
por: Umegaki H
Publicado: (2014)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti JC, et al.
Publicado: (2016)

Hearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture
por: Fatin N. Zainul Abidin, et al.
Publicado: (2021)

Laypersons’ Priority-Setting Preferences for Allocating a COVID-19 Patient to a Ventilator: Does a Diagnosis of Alzheimer’s Disease Matter?
por: Werner P, et al.
Publicado: (2020)

Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population
por: Tao QQ, et al.
Publicado: (2014)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Editorial: What's in a name? || Free Paper ||
por: Richard F Walker
Publicado: (2007)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Dementia Diagnoses and Treatment in Geriatric Ward Patients: A Cross-Sectional Study in Poland
por: Wojszel ZB
Publicado: (2020)

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
por: Jeong HR, et al.
Publicado: (2015)

Model Identifies Genetic Predisposition of Alzheimer’s Disease as Key Decider in Cell Susceptibility to Stress
por: Ioanna C. Stefani, et al.
Publicado: (2021)